Your browser doesn't support javascript.
loading
Development of the predicted and standardized carbapenem usage metric: Analysis of the Japanese Diagnosis Procedure Combination payment system data.
Maeda, Masayuki; Muraki, Yuichi; Anno, Yuka; Sawa, Akihiro; Kusama, Yoshiki; Ishikane, Masahiro; Ohmagari, Norio; Ohge, Hiroki.
  • Maeda M; Division of Infection Control Sciences, Department of Clinical Pharmacy, School of Pharmacy, Showa University, 1-4-5 Hatanodai, Shinagawa-ku, Tokyo, Japan. Electronic address: m-maeda@pharm.showa-u.ac.jp.
  • Muraki Y; Department of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, Kyoto, Japan.
  • Anno Y; Division of Infection Control Sciences, Department of Clinical Pharmacy, School of Pharmacy, Showa University, 1-4-5 Hatanodai, Shinagawa-ku, Tokyo, Japan.
  • Sawa A; Laboratory of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hiroshima International University, Hiroshima, Japan.
  • Kusama Y; Antimicrobial Resistance Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ishikane M; Antimicrobial Resistance Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ohmagari N; Antimicrobial Resistance Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ohge H; Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan.
J Infect Chemother ; 26(6): 633-635, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32146108
This study aimed to develop a metric for standardized and predicted carbapenem consumption using the Diagnosis Procedure Combination payment system database and patients' characteristics. Based on Diagnosis Procedure Combination data analysis, the developed metric will provide useful benchmarks that stewardship programs can use to help drive improvements.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carbapenémicos / Revisión de la Utilización de Medicamentos / Benchmarking / Ajuste de Riesgo / Programas de Optimización del Uso de los Antimicrobianos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Pregnancy Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carbapenémicos / Revisión de la Utilización de Medicamentos / Benchmarking / Ajuste de Riesgo / Programas de Optimización del Uso de los Antimicrobianos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Pregnancy Idioma: En Año: 2020 Tipo del documento: Article